| 2.4 |
7.3 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
| 1.4 |
8.2 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 1.3 |
4.0 |
GO:0010989 |
regulation of high-density lipoprotein particle clearance(GO:0010982) negative regulation of low-density lipoprotein particle clearance(GO:0010989) regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 1.2 |
4.6 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 1.0 |
3.1 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.8 |
2.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.8 |
5.5 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.8 |
3.1 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.7 |
2.0 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.6 |
1.9 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.5 |
2.7 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.5 |
1.6 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) notochord formation(GO:0014028) |
| 0.5 |
1.6 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.5 |
1.6 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
| 0.5 |
2.9 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.5 |
1.9 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.4 |
1.6 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.4 |
1.2 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.4 |
1.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.4 |
3.5 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.3 |
3.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.3 |
2.3 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 |
1.2 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.3 |
2.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
1.7 |
GO:0032908 |
transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 0.3 |
1.7 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.3 |
0.8 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) elastin metabolic process(GO:0051541) connective tissue replacement(GO:0097709) |
| 0.3 |
0.8 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 |
1.0 |
GO:0034337 |
RNA folding(GO:0034337) DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) regulation of DNA methylation(GO:0044030) |
| 0.2 |
0.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
1.8 |
GO:1902743 |
regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
| 0.2 |
0.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
1.8 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.2 |
0.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
2.2 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.2 |
0.5 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.2 |
0.5 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
0.7 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 |
0.6 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 |
1.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
0.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
2.5 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.1 |
2.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) tongue development(GO:0043586) |
| 0.1 |
5.1 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.6 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.3 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.0 |
GO:0055069 |
cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
| 0.1 |
0.4 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.2 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.6 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.9 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
1.9 |
GO:0015893 |
drug transport(GO:0015893) |
| 0.1 |
5.1 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
1.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
0.4 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.1 |
1.3 |
GO:0070670 |
response to interleukin-4(GO:0070670) |
| 0.1 |
0.8 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.2 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.1 |
2.5 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
5.6 |
GO:0032387 |
negative regulation of intracellular transport(GO:0032387) |
| 0.1 |
0.7 |
GO:0006069 |
ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.3 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 |
0.9 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
5.5 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.1 |
0.7 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.5 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
4.8 |
GO:0017148 |
negative regulation of translation(GO:0017148) |
| 0.1 |
1.2 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.1 |
0.2 |
GO:0016265 |
regulation of vascular smooth muscle contraction(GO:0003056) obsolete death(GO:0016265) |
| 0.1 |
0.4 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 |
0.3 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
1.2 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 |
0.2 |
GO:0003079 |
obsolete positive regulation of natriuresis(GO:0003079) response to ozone(GO:0010193) operant conditioning(GO:0035106) positive regulation of action potential(GO:0045760) |
| 0.1 |
0.7 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 |
0.2 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.5 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.7 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.2 |
GO:0006081 |
cellular aldehyde metabolic process(GO:0006081) |
| 0.0 |
0.2 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.7 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.8 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.0 |
0.1 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.0 |
0.1 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.0 |
0.1 |
GO:0044321 |
cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
| 0.0 |
0.5 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.0 |
0.6 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
8.3 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.0 |
1.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.7 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.1 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.0 |
1.6 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.0 |
0.7 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.0 |
0.3 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.8 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.7 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
3.3 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.0 |
0.9 |
GO:0035338 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
2.7 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
1.9 |
GO:0030041 |
actin filament polymerization(GO:0030041) |
| 0.0 |
1.0 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
0.2 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
3.0 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.8 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.9 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.0 |
0.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
2.8 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.0 |
0.2 |
GO:0006551 |
leucine metabolic process(GO:0006551) |
| 0.0 |
0.6 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
1.1 |
GO:0097479 |
synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
| 0.0 |
0.3 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.3 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.4 |
GO:0042493 |
response to drug(GO:0042493) |
| 0.0 |
0.1 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.3 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.3 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.0 |
0.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.2 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.5 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.0 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) striated muscle adaptation(GO:0014888) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.6 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.4 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.4 |
GO:0036503 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
| 0.0 |
0.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.2 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.8 |
GO:0006914 |
autophagy(GO:0006914) |
| 0.0 |
0.1 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.0 |
1.8 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
0.7 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
1.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.6 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
0.9 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 |
0.3 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 |
0.6 |
GO:0007049 |
cell cycle(GO:0007049) |
| 0.0 |
0.4 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
